This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Johns Hopkins University. Active years: 2014-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2024
Title: Renata T Kashiwabuchi: Innovator in Eye Therapeutics
Introduction
Renata T Kashiwabuchi is a prominent inventor based in Baltimore, MD (US). She has made significant contributions to the field of eye therapeutics, holding a total of five patents. Her work focuses on innovative drug delivery systems aimed at treating various eye disorders.
Latest Patents
Among her latest patents is a groundbreaking invention related to the sustained delivery of therapeutic agents to an eye compartment. This patent describes compositions and methods for treating eye disorders by administering a drug delivery system that contains a particle with a core and a specialized coating. The coating is designed to present a hydrophilic region to the surrounding environment, enhancing the effectiveness of the therapeutic agent. The invention aims to reduce inflammation or intraocular pressure (IOP) after administration, demonstrating improved outcomes compared to uncoated particles.
Career Highlights
Renata T Kashiwabuchi is affiliated with The Johns Hopkins University, where she continues her research and development in the field of ophthalmology. Her innovative approaches have positioned her as a key figure in advancing therapeutic options for patients with eye conditions.
Collaborations
Renata has collaborated with esteemed colleagues such as Peter John McDonnell and Yasin A Khan, further enriching her research endeavors and expanding the impact of her work in the medical community.
Conclusion
Renata T Kashiwabuchi's contributions to eye therapeutics through her innovative patents and collaborations highlight her dedication to improving patient care. Her work continues to pave the way for advancements in the treatment of eye disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
